The largest database of trusted experimental protocols

4 protocols using ampicillin ap

1

Culturing Bacterial Strains for Experimentation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacterial strains and plasmids used are listed in S1 Table. Escherichia coli strains DH5α and expression strain BL21DE3pLysS as well as the B. pseudomallei strain K96243 were cultured in Luria-Bertani (LB) medium or LB agar at 37°C. Unless stated otherwise, the concentrations of antibiotics added to LB medium for E. coli were as follows: ampicillin (Ap, Sigma-Aldrich, Germany), 100 μg/ml and/or chloramphenicol (Cm, Sigma-Aldrich, Germany), 25 μg/ml.
+ Open protocol
+ Expand
2

Culturing Bacterial Strains and Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
All bacterial strains and plasmids used are listed in Table S1. Escherichia coli strains DH5α and expression strains BL21(DE3)pLysS as well as the B. pseudomallei strain K96243 were cultured in lysogeny broth (LB) medium, LB agar or M9 minimal medium at 37°C. The concentrations of antibiotics added were as follows, unless stated otherwise: 100 μg/ml ampicillin (Ap, Sigma-Aldrich, Germany), 50 µg/ml kanamycin (Km, Carl Roth, Germany) and 25 μg/ml chloramphenicol (Cm, Sigma-Aldrich, Germany).
+ Open protocol
+ Expand
3

Bacterial Strains and Phage Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial strains, bacteriophages and plasmids used in this study are listed in Table 3. The E. coli O157:H7 C7927 bacterial strain was used for the cultivation of phage ΦV1032 (link). Homologous recombination was carried out in a lysogenic strain E. coli O157:H7 C7927 (ΦV10) bearing the lambda Red expression plasmid pKD46. For the construction of ΦV10 reporter phage, bacterial strains were grown in Luria-Bertani (LB) broth (Difco Laboratories, MI) or LB agar plates supplemented with antibiotics as needed [ampicillin (Ap), 100 μg ml−1; kanamycin (Kan), 50 μg ml−1 (Sigma-Aldrich, MO)]. Salt-Optimized Carbon broth medium (SOC) (Clontech Laboratories, Inc, CA) was used for recovery of cells after electroporation. Modified tryptone soya broth (Oxoid Ltd., UK) containing 1% casamino acids (VWR International, PA) with novobiocin (Sigma-Aldrich, MO) of 8 mg l−1 (mTSB + n) was used for ground beef enrichment as specified by the USDA-FSIS protocol33 34 . Cell dilutions were done in phosphate buffered saline (PBS) (8 mM Na2HPO4, 6 mM NaH2PO4, 145 mM NaCl, pH7.6). Phage buffer (50 mM Tris, 100 mM MgCl2, pH7.6) was used to dilute and preserve the phage stock. LB Top agar (1% (wt/vol) tryptone (Becton Dickinson, NJ), 1% (wt/vol) NaCl (Macron, PA), 0.5% (wt/vol) yeast extract (Hardy Diagnostics, CA) and 0.6% (wt/vol) agar (Alfa Aesar, MA)) was used for the overlay plaque assay.
+ Open protocol
+ Expand
4

Streptococcus agalactiae Isolation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Streptococcusagalactiae GD201008-001 was isolated in 2010 from tilapia with meningoencephalitis in Guangdong Province, China [21 (link)]. GD201008-001 wild-type strain (WT) and its derived luxS mutant strain (ΔluxS) and the luxS complemented strain (CΔluxS) [13 (link)] were maintained in Todd-Hewitt broth (THB) or in chemically defined medium (CDM) [22 (link)]. Escherichia coli was cultured in Luria–Bertani (LB) medium. For plasmids screening required, media were supplemented with antibiotics using the concentration below: 100 μg/mL spectinomycin (Sp, Sigma, St. Louis, MO, USA), 10 μg/mL erythromycin (Em, Sigma), 100 μg/mL kanamycin (Km, Sigma) or 100 μg/mL ampicillin (Ap, Sigma). The details of bacterial strains and plasmids are listed in Additional file 1. Macrophage cell line RAW 264.7 were maintained in DMEM (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS, Gibco).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!